PT  - JOURNAL ARTICLE
AU  - Kiselev, I.N.
AU  - Akberdin, I.R.
AU  - Kolpakov, F.A.
TI  - A Delay Differential Equation approach to model the COVID-19 pandemic
AID  - 10.1101/2021.09.01.21263002
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.01.21263002
4099  - http://medrxiv.org/content/early/2021/09/05/2021.09.01.21263002.short
4100  - http://medrxiv.org/content/early/2021/09/05/2021.09.01.21263002.full
AB  - SEIR (Susceptible - Exposed - Infected - Recovered) approach is a classic modeling method that has frequently been applied to the study of infectious disease epidemiology. However, in the vast majority of SEIR models and models derived from them transitions from one population group to another are described using the mass-action law which assumes population homogeneity. That causes some methodological limitations or even drawbacks, particularly inability to reproduce observable dynamics of key characteristics of infection such as, for example, the incubation period and progression of the disease’s symptoms which require considering different time scales as well as probabilities of different disease trajectories. In this paper, we propose an alternative approach to simulate the epidemic dynamics that is based on a system of differential equations with time delays to precisely reproduce a duration of infectious processes (e.g. incubation period of the virus) and competing processes like transition from infected state to the hospitalization or recovery. The suggested modeling approach is fundamental and can be applied to the study of many infectious disease epidemiology. However, due to the urgency of the COVID-19 pandemic we have developed and calibrated the delay-based model of the epidemic in Germany and France using the BioUML platform. Additionally, the stringency index was used as a generalized characteristic of the non-pharmaceutical government interventions implemented in corresponding countries to contain the virus spread. The numerical analysis of the calibrated model demonstrates that adequate simulation of each new wave of the SARS-CoV-2 virus spread requires dynamic changes in the parameter values during the epidemic like reduction of the population adherence to non-pharmaceutical interventions or enhancement of the infectivity parameter caused by an emergence of novel virus strains with higher contagiousness than original one. Both models may be accessed and simulated at https://gitlab.sirius-web.org/covid-19/dde-epidemiology-model utilizing visual representation as well as Jupyter Notebook.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported financially by the RFBR (#20-04-60355 Development of a multi-scale immuno-epidemiological mathematical model COVID-19, taking into account the impact on the economy of the region and the scenarios of authority actions)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our research does not involve any work with patients or personal data or experimental work. It is purely mathematical model using publicly available data. Thus not IRV ethics approval was needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from Our World In Data website. Datasets selected for particular regions are also available via the web interface of BioUML software accessible through dedicated gitlab page. https://gitlab.sirius-web.org/covid-19/dde-epidemiology-model. https://ourworldindata.org/